Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula empírica (notación de Hill):
Sb
Número CAS:
Peso molecular:
121.76
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12141704
MDL number:
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleassay
95%
form
foil
manufacturer/tradename
Goodfellow 465-742-20
resistance
41.7 μΩ-cm
size × thickness
50 x 50 mm × 0.01 mm
bp
1635 °C (lit.)
density
6.69 g/mL at 25 °C (lit.)
SMILES string
[Sb]
InChI
1S/Sb
InChI key
WATWJIUSRGPENY-UHFFFAOYSA-N
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
Clase de almacenamiento
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
M J Nash et al.
Journal of environmental monitoring : JEM, 2(2), 97-109 (2001-03-17)
Methodologies for the environmental analysis of total antimony and aqueous chemical speciation are critically reviewed, including preparation techniques for aqueous and solid matrices and the determination of solid state partitioning and recommendations are given for future research directions. Concentrations of
F Welle et al.
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 28(1), 115-126 (2010-12-25)
Plastics bottles made from polyethylene terephthalate (PET) are increasingly used for soft drinks, mineral water, juices and beer. In this study a literature review is presented concerning antimony levels found both in PET materials as well as in foods and
Pankaj Sharma et al.
Acta pharmacologica Sinica, 29(8), 881-890 (2008-07-31)
Antimony, a natural element that has been used as a drug for over more than 100 years, has remarkable therapeutic efficacy in patients with acute promyelocytic leukemia. This review focuses on recent advances in developing antimony anticancer agents with an